No connection

Search Results

AXS

NEUTRAL
$102.07 Live
AXIS Capital Holdings Limited · NYSE
Target $120.91 (+18.5%)
$84.81 52W Range $110.34
Overview AI Snowflake Price Valuation Profitability Growth Health Peers Insiders

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
$7.98B
P/E
8.53
ROE
16.3%
Profit margin
16.1%
Debt/Equity
0.23
Dividend yield
1.71%

AI Analysis

AI-powered fundamental assessment

Confidence
72%
AXS exhibits a weak Piotroski F-Score of 2/9, signaling significant financial health concerns, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite this, the company trades at a low P/E of 8.53 versus sector average of 20.94, shows strong recent earnings growth (YoY +83.3%), and beats estimates consistently, with a favorable analyst target of $120.91. However, deteriorating technical trend (0/100), bearish insider activity, and weak liquidity ratios (Current Ratio: 0.70, Quick Ratio: 0.19) counterbalance valuation appeal. The stock appears reasonably valued near $102 but faces structural balance sheet risks and negative insider sentiment.

Key Strengths

Attractive valuation with P/E of 8.53 well below sector average of 20.94
Strong year-over-year earnings growth of 83.3% and consistent earnings beat streak (3 of last 4 quarters)
Low debt burden with Debt/Equity ratio of 0.23, indicating conservative capital structure
High return on equity (ROE) of 16.27%, above sector median and indicative of efficient equity use
Analyst consensus supports upside with a $120.91 target price, implying ~18% potential return

Key Risks

Very weak Piotroski F-Score of 2/9, indicating poor financial health and potential operational deterioration
Critically low liquidity: Current Ratio of 0.70 and Quick Ratio of 0.19 suggest near-term solvency risk
Bearish insider sentiment: $238.96M in insider sales with zero buys in last 6 months
Technical trend score of 0/100 indicates strong bearish momentum in price action
Missing Altman Z-Score prevents definitive distress risk assessment, but low liquidity and weak Piotroski raise red flags
AI Fair Value Estimate
Based on comprehensive analysis
$142.61
+39.7% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
56
Moderate
Value
70
Future
65
Past
60
Health
30
Dividend
55
AI Verdict
Mixed outlook: fundamentally cheap with strong earnings momentum but undermined by balance sheet fragility and insider selling.
Key drivers: Low P/E and high ROE support value, Strong earnings growth and beat rate, Weak Piotroski and liquidity ratios, Bearish technicals and insider activity, Analyst target implies upside
Confidence
75%
Value
70/100

Ref P/E, PEG, Graham Number

Positives
  • P/E of 8.53 is significantly below sector average of 20.94
  • Price/Book of 1.35 is reasonable for insurance sector
  • Graham Number of $142.61 suggests 40% upside from current $102
Watchpoints
  • Intrinsic Value of $353.12 appears overly optimistic given missing growth and cash flow data
  • Stock trades below Graham fair value but above current price, raising sustainability questions
Future
65/100

Ref Growth rates

Positives
  • Earnings Growth (YoY) of 83.3% is exceptional
  • Q/Q Earnings Growth of 67.00% shows strong momentum
  • Forward P/E of 7.71 implies continued earnings expansion
Watchpoints
  • Q/Q EPS Growth of -1.2% most recently suggests near-term slowdown
  • Revenue Growth (YoY) of 3.90% is modest and lags sector average of 43.86%
Past
60/100

Ref Historical trends

Positives
  • Consistent earnings beat rate: 3 of last 4 quarters above estimates
  • Average earnings surprise of 14.56% over last 4 quarters
  • 5Y price return of +139.7% shows strong long-term performance
Watchpoints
  • Recent 1-month price decline of -6.3% breaks prior uptrend
  • History includes large negative surprises (e.g., -72.6% in 2020)
Health
30/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Debt/Equity of 0.23 is very low, reducing leverage risk
Watchpoints
  • Piotroski F-Score of 2/9 indicates severe financial weakness
  • Current Ratio of 0.70 and Quick Ratio of 0.19 signal potential liquidity crisis
  • Altman Z-Score unavailable, limiting distress risk analysis
Dividend
55/100

Ref Yield, Payout

Positives
  • Payout ratio of 14.57% is low, indicating dividend sustainability
  • Dividend Strength score of 25/100 is low but yield is stable
Watchpoints
  • Dividend Yield of 1.71% is modest
  • No 5-year average yield data available, limiting trend analysis

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$102.07
Analyst Target
$120.91
Upside/Downside
+18.5%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for AXS and closest competitors.

Updated 2026-01-23
AXS
AXIS Capital Holdings Limited
Primary
5Y
+139.7%
3Y
+87.3%
1Y
+17.7%
6M
+5.2%
1M
-6.3%
1W
+2.1%
GGA
Grupo Financiero Galicia S.A.
Peer
5Y
+740.1%
3Y
+417.2%
1Y
-5.0%
6M
+41.4%
1M
+8.9%
1W
+3.7%
FDS
FactSet Research Systems Inc.
Peer
5Y
-30.1%
3Y
-43.8%
1Y
-46.9%
6M
-20.7%
1M
+15.6%
1W
-3.7%
BPO
Popular, Inc.
Peer
5Y
+138.1%
3Y
+95.5%
1Y
+24.0%
6M
+7.1%
1M
-3.2%
1W
-4.8%
SNE
StoneX Group Inc.
Peer
5Y
+445.4%
3Y
+244.0%
1Y
+98.1%
6M
+58.6%
1M
+52.2%
1W
+14.1%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
8.53
Forward P/E
7.71
PEG Ratio
N/A
P/B Ratio
1.35
P/S Ratio
1.27
EV/Revenue
1.44
EV/EBITDA
6.97
Market Cap
$7.98B

Profitability

Profit margins and return metrics

Profit Margin 16.08%
Operating Margin 22.29%
Gross Margin 30.75%
ROE 16.27%
ROA 2.32%

Growth

Revenue and earnings growth rates

Revenue Growth +3.9%
Earnings Growth +83.3%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth +67.0%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.23
Low debt
Current Ratio
0.7
Weak
Quick Ratio
0.19
Poor
Cash/Share
$10.94

Quarterly Earnings History

EPS performance vs analyst estimates

2026-01-28
$N/A
2025-10-29
$3.25
+13.4% surprise
2025-07-29
$3.29
+12.3% surprise
2025-04-30
$3.17
+18.0% surprise

Financial Services Sector Comparison

Comparing AXS against 820 companies in the Financial Services sector (141 bullish, 351 neutral, 328 bearish)
P/E Ratio
8.53
This Stock
vs
36.01
Sector Avg
-76.3% (Discount)
Return on Equity (ROE)
16.27%
This Stock
vs
-0.73%
Sector Avg
-2320.7% (Below Avg)
Profit Margin
16.08%
This Stock
vs
91.62%
Sector Avg
-82.5% (Weaker)
Debt to Equity
0.23
This Stock
vs
1.36
Sector Avg
-82.8% (Less Debt)
Revenue Growth
3.9%
This Stock
vs
35.27%
Sector Avg
-88.9% (Slower)
Current Ratio
0.7
This Stock
vs
3.18
Sector Avg
-77.9% (Weaker)

Similar Companies

Peer comparison within the same industry

AXS AXIS Capital...
NEUTRAL
Mkt Cap
$8.0B
P/E
8.5
ROE
16.3%
Price
$102.07
GGAL Grupo...
BEARISH
Mkt Cap
$8.0B
P/E
53.9
ROE
2.5%
Price
$47.93
 Compare with AXS
FDS FactSet...
BEARISH
Mkt Cap
$8.2B
P/E
14.4
ROE
28.1%
Price
$224.12
 Compare with AXS
BPOP Popular, Inc.
NEUTRAL
Mkt Cap
$8.2B
P/E
11.2
ROE
13.1%
Price
$121.97
 Compare with AXS
SNEX StoneX Group Inc.
BULLISH
Mkt Cap
$8.3B
P/E
23.8
ROE
16.7%
Price
$106.03
 Compare with AXS

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

MILLEGAN MICHAEL
Director
Stock Award
2026-01-15
1,594 shares
HARDWICK ELANOR
Director
Stock Award
2026-01-15
1,594 shares
THEIS AXEL
Director
Stock Award
2026-01-15
1,594 shares
BECKER WILLIAM MARSTON
Director
Stock Award
2026-01-15
2,840 shares
DAVIS CHARLES A.
Director
Stock Award
2026-01-15
2,840 shares
GALANSKI STANLEY ADAM
Director
Stock Award
2026-01-15
1,594 shares
DOWLING ANNE MELISSA
Director
Stock Award
2026-01-15
1,594 shares
RAMEY THOMAS C
Director
Stock Award
2026-01-15
1,594 shares
ZLATKUS LIZABETH H
Director
Stock Award
2026-01-15
1,843 shares
YASTINE BARBARA A
Director
Stock Award
2026-01-15
1,594 shares
SMITH HENRY BLACKBURN
Director
Stock Award
2026-01-15
1,594 shares
BOLOVINOS ATHANASIOS TOM
Officer
Stock Award
2025-12-02
2,263 shares
DAVIS CHARLES A.
Director
Sell
2025-11-19
2,404,133 shares · $237,768,754
SMITH HENRY BLACKBURN
Director
Sell
2025-08-21
3,500 shares · $345,345
DRAPER DANIEL J
Officer
Sell
2025-08-20
4,305 shares · $420,039
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
11 analysts
Wells Fargo
2026-01-13
Maintains
Overweight Overweight
Keefe, Bruyette & Woods
2026-01-06
Maintains
Outperform Outperform
B of A Securities
2026-01-06
down
Buy Neutral
Mizuho
2025-12-16
init
Outperform
RBC Capital
2025-11-25
init
Outperform
Keefe, Bruyette & Woods
2025-11-24
Maintains
Outperform Outperform
Keefe, Bruyette & Woods
2025-11-04
Maintains
Outperform Outperform
Goldman Sachs
2025-10-14
init
Neutral
UBS
2025-10-08
Maintains
Buy Buy
Wells Fargo
2025-10-08
up
Equal-Weight Overweight

Past News Coverage

Recent headlines mentioning AXS from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI Chat
Markets
Profile